Federated Hermes Inc. increased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 28.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 79,490 shares of the medical research company’s stock after acquiring an additional 17,762 shares during the quarter. Federated Hermes Inc.’s […]